A detailed history of Wealth Plan Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Plan Investment Management, LLC holds 72,171 shares of ABBV stock, worth $12.7 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
72,171
Previous 67,168 7.45%
Holding current value
$12.7 Million
Previous $11.5 Million 23.72%
% of portfolio
1.54%
Previous 1.88%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $819,691 - $997,247
5,003 Added 7.45%
72,171 $14.3 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $241,162 - $281,624
-1,558 Reduced 2.27%
67,168 $11.5 Million
Q1 2024

May 16, 2024

SELL
$159.82 - $182.1 $164,294 - $187,198
-1,028 Reduced 1.47%
68,726 $12.5 Million
Q4 2023

Jan 05, 2024

BUY
$137.6 - $154.97 $476,233 - $536,351
3,461 Added 5.22%
69,754 $10.8 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $1.27 Million - $1.47 Million
9,498 Added 16.72%
66,293 $9.88 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $3.01 Million - $3.49 Million
22,536 Added 65.78%
56,795 $8.47 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $3.56 Million - $4.42 Million
26,829 Added 361.09%
34,259 $4.62 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $7.58 Million - $9.44 Million
-57,219 Reduced 88.51%
7,430 $1 Million
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $7.71 Million - $8.88 Million
-53,335 Reduced 45.21%
64,649 $10.3 Million
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $2.06 Million - $2.47 Million
14,904 Added 14.46%
117,984 $19.1 Million
Q3 2022

Dec 12, 2022

BUY
$134.21 - $153.93 $13 Million - $14.9 Million
97,030 Added 1603.8%
103,080 $17.1 Million
Q1 2022

Sep 07, 2022

BUY
$131.98 - $163.75 $798,478 - $990,687
6,050 New
6,050 $889,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Plan Investment Management, LLC Portfolio

Follow Wealth Plan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Investment Management, LLC with notifications on news.